PHILADELPHIA, February 22, 2023 – TREND Community, a digital health analytics company that turns the conversations of rare, chronic, and emerging disease communities into actionable
PHILADELPHIA, February 16, 2023 – TREND Community, a digital health analytics company with the bold vision to revolutionize the world’s understanding of diseases, today announced
TREND Community is honored to present two posters at the World Orphan Drug Congress USA 2022 on July 11-13 in Boston, MA. These two posters*
TREND Community is excited to announce the launch of a “Sleep in Rare” Evidence Accelerator. Stay tuned for more details.
Dear Community, Despite some setbacks, disappointments, and unforeseen challenges, 2021 was a year of unprecedented growth for TREND. To kick-off off the year, we matched
Philadelphia, Pa — September 22, 2021 — Today, TREND Community announced a collaboration with Takeda Pharmaceutical Company Limited (“Takeda”) to advance their shared commitment to
Click here to watch the video. Rare Disease Week on Capitol Hill officially starts today, and an incredible group of people will come together to
To use a screen reader, or access links, the text is copied below: 2020 was a transformative year for TREND, the disease communities we work
Over the last year, the kinds of clinical trials that precede a drug’s approval have been in the headlines more than ever. The way in
Implementing any formative policy is arduous. Call it partisan politics, call it division, the fact of the matter is enacting change is hard. The Affordable
